The U.S. Supreme Court is poised to deliver a significant ruling this month regarding Tennessee’s controversial ban on gender-affirming care for minors, a decision that could set a precedent for healthcare rights for transgender youth across the nation.
Passed in March 2023, Tennessee’s Senate Bill 0001 prohibits healthcare procedures, including hormone therapy and puberty blockers, aimed at allowing minors to live in alignment with their gender identity.
While the law makes exceptions for treatment of minors who do not identify as transgender, or for unrelated medical conditions such as early-onset puberty, many argue it discriminates against transgender youth by denying essential medical care.
The law justifies its restrictions by asserting a “compelling interest” in preserving minors’ appreciation of their biological sex and ensuring their future ability to procreate.
In response to the law, three transgender teenagers and their families filed a lawsuit against state officials, arguing it infringes upon their constitutional rights to equal protection under the law.
Initially supported by the Biden administration, a federal injunction on the law was granted but later overturned by an appellate court in 2023.
The ongoing legal battle is now centered on Tennessee’s Attorney General Jonathan Skrmetti, who is defending the law in the Supreme Court after the case was escalated in November 2023, focusing on the ban on hormone therapy and puberty blockers.
Experts suggest that the court’s decision could have lasting impacts not just on gender-affirming care, but also extend to broader reproductive rights, including access to birth control and abortion.
Leila Abolfazli, director of National Strategy on Abortion Rights at the National Women’s Law Center, expressed concern over the government’s encroachment into personal medical decisions, signaling potential implications for areas like birth control and fertility care.
While comparisons have been drawn to Dobbs v. Jackson Women’s Health Organization, the 2022 case that overturned the constitutionally protected right to abortion, Skrmetti’s brief filed in October asks the Supreme Court to expand its ruling from that case to allow states to restrict various forms of healthcare based on situational circumstances.
As public attention turns to this case, it’s important to recognize the broader context surrounding gender-affirming care for minors in the United States.
According to research from the Williams Institute at UCLA, there are over 1.6 million transgender individuals in the United States, with approximately 300,000 between the ages of 13 and 17.
The majority of these individuals reside in Republican-led states, where legislative efforts to restrict gender-affirming care have been rampant.
Since 2021, 24 states have enacted laws banning gender-affirming care for minors, with Arizona and New Hampshire also prohibiting gender-affirming surgery.
Legal challenges are currently underway in 17 states contesting the legality of these restrictions.
In Montana, a law aimed at limiting gender-affirming care was blocked in May, while Arkansas, the first state to pass such a ban, saw its legislation struck down by federal judges in 2023.
Additionally, President Donald Trump had previously signed an executive order declaring the federal government would not ‘fund, sponsor, promote, assist or support’ gender-affirming care for individuals under the age of 19, a directive that is facing opposition in courts across Washington and Maryland.
As the Supreme Court prepares to render judgment on Tennessee’s law, advocates and legal experts are bracing for a decision that could reshape the legal landscape for transgender rights and healthcare accessibility throughout the United States.
image source from：https://www.context.news/socioeconomic-inclusion/us-ruling-to-impact-trans-healthcare-reproductive-rights
